Prognostic implications of body composition changes in patients with non-metastatic pancreatic adenocarcinoma treated with mFOLFIRINOX
BackgroundComputed tomography (CT) enables non-invasive, comprehensive assessment of body composition in patients with cancer. In pancreatic ductal adenocarcinoma (PDAC), where weight and body composition change during treatment are common, serial CT evaluation may provide prognostic insights.Method...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2026-03-01
|
| Серии: | Frontiers in Oncology |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1762299/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
